- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02496130
Perioperative Outcomes of Common Methods of Minimally Invasive Contained Tissue Extraction
January 23, 2019 updated by: Jon I. Einarsson, Brigham and Women's Hospital
A Partners Prospective Study Assessing the Perioperative Outcomes of Common Methods of Minimally Invasive Contained Tissue Extraction
The goal of this study is to compare common methods of tissue extraction at the time of minimally invasive surgery.
Study Overview
Status
Completed
Conditions
Detailed Description
The goal of this study is to compare common methods of tissue extraction at the time of minimally invasive surgery, including vaginal extraction and mini-laparotomy; both performed within a containment system.
The primary aim is to assess return to normal daily activities after each of the surgical techniques.
Return to daily activities will be recorded on a post-operative patient activity diary recording the following tasks: a) work (if applicable), b) domestic tasks, c) driving a vehicle (if applicable) and d) physical exercise (if applicable).
Additional information regarding post-operative pain (measured on a Likert scale), potential complications of each technique, such as tearing of the bag or leakage, and peri- and post-operative outcomes will be collected.
In order to aid in detection of leakage, blue dye (either indigo carmine or methylene blue) will be added to the containment bag prior to morcellation.
Study Type
Observational
Enrollment (Actual)
70
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
Boston, Massachusetts, United States, 02115
- Brigham & Women's Hospital
-
Boston, Massachusetts, United States, 02130
- Faulkner Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
70 adult women scheduled to undergo a laparoscopic hysterectomy
Description
Inclusion Criteria:
- 18 years of age or greater
- eligible to undergo laparoscopic Hysterectomy, as determined clinically by the operating surgeon
Exclusion Criteria:
- suspected malignancy
- medical illness precluding laparoscopy
- inability to give informed consent
- allergy to indigo carmine or methylene blue dye
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
minilaparotomy
Subjects in this group will have tissue (uterus) extracted via mini-laparotomy incision with knife morcellation.
Morcellation will be performed within a containment system.
Method of extraction/group assignment will be determined clinically by the operating surgeon based on patient characteristics and patient preference.
|
vaginal extraction
Subjects in this group will have tissue (uterus) extracted via vaginal extraction with knife morcellation.
Morcellation will be performed within a containment system.
Method of extraction/group assignment will be determined clinically by the operating surgeon based on patient characteristics and patient preference.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Return to daily activities
Time Frame: assessed between 2 and 6 weeks after surgery (at post-op visit)
|
Return to daily activities will be recorded on a post-operative patient activity diary recording the following tasks: a) work (if applicable), b) domestic tasks, c) driving a vehicle (if applicable) and d) physical exercise (if applicable).
|
assessed between 2 and 6 weeks after surgery (at post-op visit)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
OR Time
Time Frame: At the time of surgery
|
minutes from procedure start to procedure end
|
At the time of surgery
|
Estimated Blood Loss
Time Frame: At the time of surgery
|
ml of blood loss based on surgeon estimate
|
At the time of surgery
|
Spillage of the morcellated tissue or fluids in the abdomen and pelvis
Time Frame: At the time of surgery
|
Following morcellation and removal of the bag, the abdomen and pelvis will be carefully examined for any signs of spillage of fluid, tissue or blue dye as well as the integrity of the containment system by the surgeon
|
At the time of surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jon I Einarsson, MD, PhD, MPH, Brigham and Women's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (Actual)
September 1, 2017
Study Completion (Actual)
September 1, 2017
Study Registration Dates
First Submitted
July 9, 2015
First Submitted That Met QC Criteria
July 9, 2015
First Posted (Estimate)
July 14, 2015
Study Record Updates
Last Update Posted (Actual)
January 25, 2019
Last Update Submitted That Met QC Criteria
January 23, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2015P000230
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysterectomy
-
Zuyderland Medisch CentrumCatharina Ziekenhuis EindhovenRecruitingHysterectomy | Natural Orifice Transluminal Endoscopic Surgery | Vaginal HysterectomyNetherlands
-
Muğla Sıtkı Koçman UniversityCompletedAbdominal Hysterectomy | Laparoscopic Hysterectomy
-
Università degli Studi di FerraraRecruiting
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompleted
-
University Hospitals Cleveland Medical CenterWithdrawn
-
Atlantic Health SystemUnknownHysterectomyUnited States
-
Case Comprehensive Cancer CenterWithdrawnHysterectomy
-
Cairo UniversityUnknown
-
Mayo ClinicTerminated
-
University Hospital, LinkoepingCompleted